sphingosine-phosphorylcholine and safingol

Sphingolipids contribute to modulation of two opposing cell processes, cell growth and apoptotic cell death; ceramide and sphingosine promote the latter and sphingosine-1-phosphate triggers the former. Thrombin, a pro-inflammatory protease that is regulated by the blood coagulation cascade, exerts similar effects depending on cell type. Here we report a new mechanism for cross-talk between sphingolipid metabolism and thrombin generation. Sphingosine and sphinganine, but not ceramide or sphingosine-1-phosphate, down-regulated thrombin generation on platelet surfaces (IC(50) = 2.4 and 1.4 microm for sphingosine and sphinganine, respectively) as well as in whole plasma clotting assays. Thrombin generation was also inhibited by glucosylsphingosine, lysosphingomyelin, phytosphingosine, and primary alkylamines with >10 carbons. Acylation of the amino group ablated anticoagulant activities. Factor Va was required for the anticoagulant property of sphingosine because prothrombin activation was inhibited by sphingosine, sphinganine, and stearylamine in the presence but not in the absence of factor Va. Sphingosine did not inhibit thrombin generation when Gla-domainless factor Xa was used in prothrombinase assays, whereas sphingosine inhibited activation of Gla-domainless prothrombin by factor Xa/factor Va in the absence of phospholipids (IC(50) = 0.49 microm). Fluorescence spectroscopy studies showed that sphingosine binds to fluorescein-labeled factor Xa and that this interaction required the Gla domain. These results imply that sphingosine disrupts interactions between factor Va and the Gla domain of factor Xa in the prothrombinase complex. Thus, certain sphingolipids may be bioactive lipid mediators of thrombin generation such that certain sphingolipid metabolites may modulate proteases that affect cell growth and death, blood coagulation, and inflammation.

Topics: Anticoagulants; Binding Sites; Blood Platelets; Carbon; Dose-Response Relationship, Drug; Down-Regulation; Factor Va; Factor Xa; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Lipid Metabolism; Lipids; Micelles; Phosphorylcholine; Protein Binding; Protein Structure, Tertiary; Prothrombin; Psychosine; Sphingolipids; Sphingosine; Thrombin

Exogenous sphingosylphosphocholine analogues and naturally occurring sphingomyelin stimulated the neurite outgrowth in cultured murine neuroblastoma cell lines, NS-20Y, Neuro2a, and N1E-115, whereas exogenous sphinganine at a non-cytotoxic concentration inhibited the neurite outgrowth in NS-20Y and Neuro2a cells. The effect of sphingosylphosphocholine on the neurite outgrowth was reversible, indicating that the extended neurites needed to be maintained by continuous stimulation. The uptake and metabolism of the exogenous [3-3H]sphingosylphosphocholine in pulse and chase experiments suggested that the radioactive ceramide and sphingomyelin, which were detected as major metabolic products, were in a precursor/product relationship. It is thus assumed that the exogenous sphingosylphosphocholine taken up by the cells is first degraded into phosphocholine and sphingosine, of which the latter is rapidly acylated to ceramide then converted to sphingomyelin by phosphocholine transfer. Metabolism of sphingosylphosphocholine through sphingomyelin synthesis in the cells may be associated with neurite outgrowth.

Topics: Animals; Cell Differentiation; Mice; Neurites; Neuroblastoma; Phosphorylcholine; Protein Kinase C; Sphingosine; Tritium; Tumor Cells, Cultured